
Glymark-M2
Glimepiride 2 mg + Metformin 500 mg (SR)
Higher-strength sustained-release Glimepiride and Metformin combination for advanced Type 2 Diabetes management.

Glimepiride 1 mg + Metformin 500 mg (SR)
Glymark-M1 is a fixed-dose combination of Glimepiride 1 mg and Metformin 500 mg in a sustained-release formulation. It supports better blood sugar control in adults with Type 2 Diabetes Mellitus inadequately managed by diet, exercise or single-agent therapy.
One tablet once or twice daily with meals, as prescribed by a diabetologist or registered medical practitioner.
General information only. Follow your physician's prescription.
Store below 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.
The information provided is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Always seek the guidance of a qualified physician regarding any medical condition or medication.

Glimepiride 2 mg + Metformin 500 mg (SR)
Higher-strength sustained-release Glimepiride and Metformin combination for advanced Type 2 Diabetes management.

Vildagliptin 50 mg + Metformin HCl 500 mg
A DPP-4 inhibitor plus Metformin combination for comprehensive Type 2 Diabetes management.

Bilastine 20 mg + Montelukast 10 mg
A dual-action anti-allergic tablet combining Bilastine and Montelukast for effective relief from allergic rhinitis and related symptoms.